Jay Chatfield Mph, Pm-Lpc

Jay Chatfield, MPH, PM-LPC, currently serves as Senior Medical Science Liaison and Medical Insights for Oncology, Hematology, and Immunology Rare Dx at Cogent Biosciences since March 2023. Prior experience includes Senior Cardiovascular-Immunology Medical Science Liaison at Kiniksa Pharmaceuticals, where notable achievements encompassed the launch of rilonacept and significant contributions to clinical operations, KOL engagement, and payer presentations. An MPH graduate from the University of Liverpool, Jay has also held positions at Chaucer Consulting, Orexigen Therapeutics, and Merck, focusing on clinical operations, market access strategies, and scientific engagement. Educational background includes a Bachelor of Arts degree in Marketing, Communications, and Sociology from Stephen F. Austin State University.